Autism Spectrum Disorder
Conditions
Interventions
This is a double-blind, randomized, placebo-controlled clinical trial lasting twelve weeks involving children and adolescents diagnosed with autism spectrum disorder. The sample population will consis
Sponsors
Universidade Federal da Paraíba
Centro de Ciências da Saúde da Universidade Federal da Paraíba
Eligibility
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: Age between 5 and 18 years; both genders; user of the rehabilitation services of the Autism Care Center; sufficient cognitive capacity to perform the method of visualizing flower essences; diagnosis of Autism Spectrum Disorder confirmed by medical report
Exclusion criteria
Exclusion criteria: Severe intellectual disability; users of flower essences prior to the start of the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in scores on the Autism Treatment Evaluation Checklist (ATEC) instrument in the dimensions of communication, sociability, cognition and behavior, evaluating changes in the behavioral and social profile of participants after the use of flower essences compared to the placebo group. Reduction in challenging behaviors reported by caregivers, such as irritability, aggression, fear, anxiety, food selectivity and sleep. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactRebeca De Queiroz
Centro de Ciências da Saúde da Universidade Federal da Paraíba
Outcome results
None listed